The chemical class known as RGD1564058 Activators encompasses a diverse range of compounds that share the common trait of influencing the expression or function of the non-coding RNA RGD1564058. This class is characterized by its ability to modulate various biochemical pathways, which in turn can alter the transcriptional landscape of cells, including the levels of non-coding RNAs such as RGD1564058. These activators operate through different mechanisms, including the inhibition of DNA methyltransferases, histone modification enzymes, and RNA polymerase, as well as by altering the methylation patterns of nucleic acids. By affecting these fundamental cellular processes, activators in this class can lead to changes in the chromatin state and subsequently impact the expression of RGD1564058, among other genes and non-coding RNAs. The way these compounds interact with the cell's machinery underscores the intricate network of regulation and control that governs gene expression, highlighting the importance of epigenetic and transcriptional dynamics in cellular function.
RGD1564058 Activators are also characterized by their influence on the cellular epigenetic landscape. This influence is exerted through the modulation of chromatin remodeling processes, such as histone acetylation and methylation, which play a pivotal role in the regulation of gene expression. By inhibiting or altering the activity of enzymes responsible for adding or removing these epigenetic marks, RGD1564058 Activators can induce a more open chromatin state, facilitating or increasing the transcription of RGD1564058. Additionally, by targeting the transcription machinery directly, some activators in this class can cause a reduction in the synthesis of RNA transcripts, which can indirectly affect the levels and activity of non-coding RNAs like RGD1564058. The actions of these compounds are indicative of the complex layers of control within the cell, where multiple pathways can converge to regulate the expression of a single non-coding RNA entity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A cytidine analog that incorporates into RNA and DNA and could possibly activate Wdr83os by inhibiting DNA methyltransferases, affecting the epigenetic regulation and expression of ncRNAs. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
A non-nucleoside DNA methyltransferase inhibitor, which could possibly activate Wdr83os by leading to changes in the methylation status of genes and consequently alter ncRNA expression. | ||||||
Ademetionine | 29908-03-0 | sc-278677 sc-278677A | 100 mg 1 g | $180.00 $655.00 | 2 | |
A universal methyl donor in biological methylation reactions, which could possibly activate Wdr83os by influencing the methylation of nucleic acids and potentially the expression of ncRNAs. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
Inhibits EZH2, which could possibly activate Wdr83os by leading to a decrease in the tri-methylation of histone H3 on lysine 27 (H3K27me3) and potential changes in chromatin state and ncRNA expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
A histone deacetylase inhibitor, which could possibly activate Wdr83os by altering chromatin structure and potentially affecting ncRNA levels by changing gene expression profiles. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
A short-chain fatty acid that acts as a histone deacetylase inhibitor, which could possibly activate Wdr83os by influencing chromatin remodeling and ncRNA expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
A metabolite of Vitamin A that regulates gene transcription via retinoic acid receptors, which could possibly activate Wdr83os by affecting ncRNA expression involved in differentiation and development pathways. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Interacts with DNA and inhibits RNA polymerase, which could possibly activate Wdr83os by affecting the transcription of both coding and non-coding RNAs. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
A diterpene triepoxide that inhibits RNA polymerase I, II, and III, which could possibly activate Wdr83os by affecting ncRNA transcription. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
Inhibits RNA polymerase II transcription elongation, which could possibly activate Wdr83os by preventing full-length transcripts and potentially altering ncRNA levels. | ||||||